| Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma. (NCT05176002) | Fujian Medical University Union Hospital | 2021-11-10 |
| CCRT With Itraconazole in Locally Advanced Squamous Esophageal Cancer (NCT04481100) | Hangzhou Cancer Hospital | 2020-10-01 |
| The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study (NCT04075305) | UMC Utrecht | 2019-02-01 |
| Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence (NCT03108885) | Mayo Clinic | 2017-10-01 |
| Prospective Study Evaluating the Feasibility of Fiducial Markers Placement for Patients With Esophageal or Rectal Cancer (NCT03057288) | Société Française d'Endoscopie Digestive | 2017-02-03 |
| Endodrill vs. Conventional Biopsy. Diagnostics and Genetic Analysis (NCT02601079) | Region Skane | 2016-09-01 |
| ESD for the Treatment of Early Barrett's Neoplasia (NCT02583087) | Hôpital Cochin | 2016-01-02 |
| Neoadjuvant Chemotherapy Versus Surgery Alone for Esophageal Squamous Cell Carcinoma (NCT02395705) | Henan Cancer Hospital | 2015-06-01 |
| trūFreeze® Spray Cryotherapy Patient Registry (NCT01802203) | US Endoscopy Group Inc. | 2013-04-01 |
| Radiofrequency in the Treatment of Barrett's Oesophagus (NCT02558504) | Hospices Civils de Lyon | 2013-01-07 |
| Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma; (NCT01745107) | Chinese Academy of Medical Sciences | 2012-10-01 |
| Outcomes After Esophageal Cancer Surgery (NCT01927016) | University Hospital, Lille | 2012-07-01 |
| Study of Additive Omega-3 Fish Oil to Palliative Chemotherapy to Treat Oesophagogastric Cancer (NCT01870791) | University Hospitals, Leicester | 2012-05-01 |
| Volume Restriction in Esophageal Carcinoma Surgery: Randomized Clinical Trial (NCT02033213) | Klinički Bolnički Centar Zagreb | 2011-06-01 |
| Definitive Chemoradiotherapy and Cetuximab in the Treatment of Locally Advanced Esophageal Cancer (NCT02636088) | Gabriella Alexandersson von Döbeln | 2011-01-01 |
| Definitive Concurrent Chemoradiotherapy With Docetaxel Plus Cisplatin Versus 5-fluorouracil Plus Cisplatin in Patients With Esophageal Squamous Cell Carcinoma (NCT02969473) | Zhu Yujia | 2010-10-01 |
| Study for Determination of Feasibility and Toxicity of Pre-Treatment With HPPH (2-1[1-Hexyloxyethyl]-2 Devinyl Pyropheophorbide-a) Photodynamic Therapy Prior to Chemoradiation in Non-Operable Patients With Obstructive Esophageal Cancer (NCT01035437) | Roswell Park Cancer Institute | 2009-12-01 |
| Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED) (NCT00423150) | Merck Sharp & Dohme LLC | 2007-01-26 |
| Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma (NCT00288119) | Case Western Reserve University | 2005-10-01 |
| Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus (NCT00431756) | Johns Hopkins University | 2002-05-01 |
| Definitive Radiotherapy for Cervical and Upper Thoracic Esophageal Cancer (ChC&UES): A Multi-center Real World Study (NCT06481449) | Hebei Medical University Fourth Hospital | 2000-01-01 |
| The Effects of Upper Airway and Digestive Tract Tumors on the Immune System (NCT00001603) | National Institute on Deafness and Other Communication Disorders (NIDCD) | 1996-12-01 |
| A Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients With Metastatic Esophageal Cancer (NCT00037089) | Edelman, Martin, M.D. | |
| Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors (NCT04681248) | Leap Therapeutics, Inc. | |